Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Institute of Biomedi (MRES)

Institute of Biomedi (MRES)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.86
Trade MRES with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0092 +27.17%
on 05/03/24
0.0139 -15.83%
on 04/25/24
+0.0003 (+2.63%)
since 04/05/24
3-Month
0.0070 +67.14%
on 02/22/24
0.0149 -21.48%
on 03/15/24
+0.0032 (+37.65%)
since 02/06/24
52-Week
0.0069 +69.57%
on 06/06/23
0.0280 -58.21%
on 07/19/23
+0.0031 (+36.05%)
since 05/04/23

Most Recent Stories

More News
MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions

/PRNewswire/ -- Institute of Biomedical Research Corp. (OTC-PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical biotechnology...

MRES : 0.0117 (+27.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Neuro-Biotech Corp. was formerly known as M45 Mining Resources Inc. On February 11, 2010, the Company changed its name to Neuro-Biotech Corp. The Company is a neuroscience medical diagnostic enterprise, which is engaged in the development and commercialization of innovative and competitive diagnostic...

See More

Key Turning Points

3rd Resistance Point 0.0149
2nd Resistance Point 0.0133
1st Resistance Point 0.0125
Last Price 0.0117
1st Support Level 0.0101
2nd Support Level 0.0085
3rd Support Level 0.0077

See More

52-Week High 0.0280
Fibonacci 61.8% 0.0199
Fibonacci 50% 0.0175
Fibonacci 38.2% 0.0150
Last Price 0.0117
52-Week Low 0.0069

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar